<?xml version="1.0" ?>
<document id="3207d738e32216ee810dcb38fdbdf73d47eafaca">
  <chunk id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c0" text="EXPERIMENTAL AND THERAPEUTIC MEDICINE Glycyrrhizin improves p75NTR-associated sciatic nerve regeneration in a BALB/c mouse model">
    <entity charOffset="92-104" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c0.e0" ontology_id="GO_0031099" text="regeneration" type="gene_function"/>
  </chunk>
  <chunk id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1" text="Glycyrrhizin has a role in immune regulation in the central nervous system, but its impact on sciatic nerve injury had not previously been reported. In this study, a BALB/c mouse model of sciatic nerve injury was used to explore the role of glycyrrhizin in sciatic nerve repair and its underlying mechanism. Glycyrrhizin with intragastric gavage of 10 and 20 mg/kg weight per day (mid-and high-dose, respectively) inhibited p75 neurotrophin receptor (p75NTR) expression at the protein and mRNA levels versus the 5 mg/kg (low-dose) group and control (0.9% NaCl solution) at one, two, four and eight weeks following sciatic nerve injury, and simultaneously improved the action potential amplitude and motor nerve conductive velocity. Combined Marsland, Glees and Erikson's silver stain and Luxol fast blue staining results indicated that high-and mid-dose glycyrrhizin promoted improved sciatic nerve myelination compared with the low-dose or control groups eight weeks after injury. Immunofluorescence staining demonstrated that glycyrrhizin had an inhibitory effect to a certain degree on local hypertrophic scar and inflammatory responses in the mouse model. In conclusion, glycyrrhizin can promote sciatic nerve regeneration and functional repair, in which doses of 10 and 20 mg/kg per day are more effective than lower doses, and such regeneration is associated with the downregulation of p75NTR.">
    <entity charOffset="52-59" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e0" ontology_id="HP_0030645" text="central" type="phenotype"/>
    <entity charOffset="668-684" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e1" ontology_id="GO_0001508" text="action potential" type="gene_function"/>
    <entity charOffset="794-798" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e2" ontology_id="GO_0033867" text="fast" type="gene_function"/>
    <entity charOffset="899-910" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e3" ontology_id="GO_0042552" text="myelination" type="gene_function"/>
    <entity charOffset="1214-1226" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e4" ontology_id="GO_0031099" text="regeneration" type="gene_function"/>
    <entity charOffset="1338-1350" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e5" ontology_id="GO_0031099" text="regeneration" type="gene_function"/>
    <pair e1="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e0" e2="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e1" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.p0" relation="true"/>
    <pair e1="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e0" e2="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e2" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.p1" relation="true"/>
    <pair e1="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e0" e2="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e3" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.p2" relation="true"/>
    <pair e1="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e0" e2="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e4" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.p3" relation="true"/>
    <pair e1="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e0" e2="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.e5" id="3207d738e32216ee810dcb38fdbdf73d47eafaca.c1.p4" relation="true"/>
  </chunk>
</document>
